Share：
Share this content in WeChat
X
[Chinese][PDF]78269
• Expert Forum •
The current status and technical advances in cardiac MRI
ZHANG Zhao-qi  XU Lei 

DOI:10.3969/j.issn.1674-8034.2013.03.012.


[Abstract] Rapid progress has been made in cardiac MRI (CMRI) over the past two decades, which has established it as a reliable technique for assessment of cardiac structure, function, perfusion, and myocardial viability. Technical innovation of CMRI allows the assessment of hemodynamic, metabolism, and coronary arteries. The study of CMRI has been expanded from anatomy and function to cellular and molecular level. CMRI is non-invasive, highly reproducible, and avoids use of radiation. Today CMR is extensively used for the diagnosis of a variety of cardiovascular diseases, clinical decision making, and prognosis evaluation. In this article, current status of CMRI will be discussed with a focus on technological innovations.
[Keywords] Magnetic resonance imaging；Heart

ZHANG Zhao-qi* Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

XU Lei Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China

*Correspondence to: Zhang ZQ, E-mail: zhaoqi5000@vip.sohu.com

Conflicts of interest   None.

Received  2013-01-23
Accepted  2013-03-08
DOI: 10.3969/j.issn.1674-8034.2013.03.012
DOI:10.3969/j.issn.1674-8034.2013.03.012.

[1]
Earls JP, Ho VB, Foo TK, et al. Cardiac MRI: recent progress and continued challenges. J Magn Reson Imaging, 2002, 16(2): 111-127.
[2]
Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol, 2004, 44(6): 1164-1171.
[3]
Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ, 2006, 175(8): 911-917.
[4]
Shehata ML, Cheng S, Osman NF, et al. Myocardial tissue tagging with cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2009, 11: 55.
[5]
Götte MJ, van Rossum AC, Twisk JWR, et al. Quantification of regional contractile function after infarction: strain analysis superior to wall thickening analysis in discriminating infarct from remote myocardium. J Am Coll Cardiol, 2001, 37(3): 808-817.
[6]
von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Cardiovascular magnetic resonance imaging in ischemic heart disease. J Magn Reson Imaging, 2012, 36(1): 20-38.
[7]
Charoenpanichkit C, Hundley WG. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2010, 12: 59.
[8]
Nandalur KR, Dwamena BA, Choudhri AF, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol, 2007, 50(14): 1343-1353.
[9]
Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J, 2008, 29(4): 480-489.
[10]
Nagel E, Klein C, Paetsch I, et al.Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation, 2003, 108(4): 432-437.
[11]
Watkins S, McGeoch R, Lyne J, et al. Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart disease. Circulation, 2009, 120(22): 2207-2213.
[12]
Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol, 2005, 184(5): 1420-1426.
[13]
Ingkanisorn WP, Kwong RY, Bohme NS, et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol, 2006, 47(7): 1427-1432.
[14]
Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet, 2003, 361(9355): 374-379.
[15]
Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med, 2000, 343(20): 1445-1453.
[16]
Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation, 1998, 97(8): 765-772.
[17]
Bluemke DA. MRI of nonischemic cardiomyopathy. AJR Am J Roentgenol, 2010, 195(4): 935-940.
[18]
Higgins CB, Herfkens R, Lipton MJ, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol, 1983, 52(1): 184-188.
[19]
Eitel I, Friedrich MG. T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson, 2011, 13: 13.
[20]
Friedrich MG, Abdel-Aty H, Taylor A, et al. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol, 2008, 51(16): 1581-1587.
[21]
Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging, 2011, 4(3): 269-278.
[22]
Chu WC, Au WY, Lam WW. MRI of cardiac iron overload. J Magn Reson Imaging, 2012, 36(5): 1052-1059.
[23]
Spuentrup E, Buecker A, Stuber M, et al. Navigator-gated coronary magnetic resonance angiography using steady-state-free-precession: comparison to standard T2-prepared gradient-echo and spiral imaging. Invest Radiol, 2003, 38(5): 263-268.
[24]
Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med, 2001, 345(26): 1863-1869.
[25]
Bi X, Carr JC, Li D. Whole-heart coronary magnetic resonance angiography at 3 Tesla in 5 minutes with slow infusion of Gd-BOPTA, a high-relaxivity clinical contrast agent. Magn Reson Med, 2007, 58(1): 1-7.
[26]
Hendel RC, Patel MR, Kramer CM, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol, 2006, 48(7): 1475-1497.
[27]
Srichai MB, Lim RP, Wong S, et al. Cardiovascular applications of phase-contrast MRI. AJR Am J Roentgenol, 2009, 192(3): 662-675.
[28]
Markl M, Kilner PJ, Ebbers T. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 2011, 13:7.
[29]
Bürk J, Blanke P, Stankovic Z, et al. Evaluation of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-sensitive 4D CMR. J Cardiovasc Magn Reson, 2012, 14: 84.
[30]
Boussel L, Rayz V, McCulloch C, et al. Aneurysm growth occurs at region of low wall shear stress: patient-specific correlation of hemodynamics and growth in a longitudinal study. Stroke, 2008, 39(11): 2997-3002.
[31]
Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA, 1999, 282(21): 2035-2042.
[32]
Muller L, Saeed M, Wilson MW, et al. Remote control catheter navigation: options for guidance under MRI. J Cardiovasc Magn Reson, 2012, 14: 33.
[33]
Kolandaivelu A, Lardo AC, Halperin HR. Cardiovascular magnetic resonance guided electrophysiology studies. J Cardiovasc Magn Reson, 2009, 11: 21.
[34]
Atalar E, Bottomley PA, Ocali O, et al. High resolution intravascular MRI and MRS by using a catheter receiver coil. Magn Reson Med, 1996, 36(4): 596-605.
[35]
Niendorf T, Sodickson DK, Krombach GA, et al. Toward cardiovascular MRI at 7 T: clinical needs, technical solutions and research promises. Eur Radiol, 2010, 20(12): 2806-2816.
[36]
von Knobelsdorff-Brenkenhoff F, Frauenrath T, Prothmann M, et al. Cardiac chamber quantification using magnetic resonance imaging at 7 Tesla--a pilot study. Eur Radiol, 2010, 20(12): 2844-2852.
[37]
Winter PM, Caruthers SD, Lanza GM, et al. Quantitative cardiovascular magnetic resonance for molecular imaging. J Cardiovasc Magn Reson, 2010, 12: 62.
[38]
Kraitchman DL, Gilson WD, Lorenz CH. Stem cell therapy: MRI guidance and monitoring. J Magn Reson Imaging, 2008, 27(2): 299-310.
[39]
Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation, 2003, 108(14): 1664-1672.
[40]
Briley-Saebo KC, Mulder WJ, Mani V, et al. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging, 2007, 26(3): 460-479.
[41]
Holloway CJ, Suttie J, Dass S, et al. Clinical cardiac magnetic resonance spectroscopy. Prog Cardiovasc Dis, 2011, 54(3): 320-327.
[42]
Beadle R, Frenneaux M. Magnetic resonance spectroscopy in myocardial disease. Expert Rev Cardiovasc Ther, 2010, 8(2): 269-277.
[43]
Friedrich MG, Niendorf T, Schulz-Menger J, et al. Blood oxygen level-dependent magnetic resonance imaging in patients with stress-induced angina. Circulation, 2003, 108(18): 2219-2223.
[44]
Wu MT, Tseng WY, Su MY, et al. Diffusion tensor magnetic resonance imaging mapping the fiber architecture remodeling in human myocardium after infarction: correlation with viability and wall motion. Circulation, 2006, 114(10): 1036-1045.
[45]
Sack I, Rump J, Elgeti T, et al. MR elastography of the human heart: noninvasive assessment of myocardial elasticity changes by shear wave amplitude variations. Magn Reson Med, 2009, 61(3): 668-677.
[46]
Xu L, Chen J, Kevin J, et al. Magnetic resonance elastography of the human abdominal aorta: a preliminary study. J Magn Reson Imaging, 2013, DOI: .

PREV MRI and MRV features of cerebral venous sinus thrombosis
NEXT Introduction of MAGNETOM AERA brain dot engine
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn